• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估非线性混合效应模型随机效应参数设计的稳健性。

Assessing robustness of designs for random effects parameters for nonlinear mixed-effects models.

作者信息

Duffull Stephen B, Hooker Andrew C

机构信息

School of Pharmacy, University of Otago, 18 Frederick St, Dunedin, New Zealand.

Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.

出版信息

J Pharmacokinet Pharmacodyn. 2017 Dec;44(6):611-616. doi: 10.1007/s10928-017-9552-y. Epub 2017 Oct 24.

DOI:10.1007/s10928-017-9552-y
PMID:29064062
Abstract

Optimal designs for nonlinear models are dependent on the choice of parameter values. Various methods have been proposed to provide designs that are robust to uncertainty in the prior choice of parameter values. These methods are generally based on estimating the expectation of the determinant (or a transformation of the determinant) of the information matrix over the prior distribution of the parameter values. For high dimensional models this can be computationally challenging. For nonlinear mixed-effects models the question arises as to the importance of accounting for uncertainty in the prior value of the variances of the random effects parameters. In this work we explore the influence of the variance of the random effects parameters on the optimal design. We find that the method for approximating the expectation and variance of the likelihood is of potential importance for considering the influence of random effects. The most common approximation to the likelihood, based on a first-order Taylor series approximation, yields designs that are relatively insensitive to the prior value of the variance of the random effects parameters and under these conditions it appears to be sufficient to consider uncertainty on the fixed-effects parameters only.

摘要

非线性模型的最优设计取决于参数值的选择。已经提出了各种方法来提供对参数值先验选择中的不确定性具有鲁棒性的设计。这些方法通常基于在参数值的先验分布上估计信息矩阵行列式(或行列式的变换)的期望。对于高维模型,这在计算上可能具有挑战性。对于非线性混合效应模型,随机效应参数方差的先验值中的不确定性的重要性问题随之而来。在这项工作中,我们探讨了随机效应参数的方差对最优设计的影响。我们发现,近似似然期望和方差的方法对于考虑随机效应的影响可能具有重要意义。基于一阶泰勒级数近似的最常见似然近似产生的设计对随机效应参数方差的先验值相对不敏感,在这些条件下,似乎仅考虑固定效应参数的不确定性就足够了。

相似文献

1
Assessing robustness of designs for random effects parameters for nonlinear mixed-effects models.评估非线性混合效应模型随机效应参数设计的稳健性。
J Pharmacokinet Pharmacodyn. 2017 Dec;44(6):611-616. doi: 10.1007/s10928-017-9552-y. Epub 2017 Oct 24.
2
Robust designs in longitudinal studies accounting for parameter and model uncertainties - application to count data.纵向研究中考虑参数和模型不确定性的稳健设计——在计数数据中的应用。
J Biopharm Stat. 2020;30(1):31-45. doi: 10.1080/10543406.2019.1607367. Epub 2019 Apr 27.
3
Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling.利用重抽样重要性采样法改进非线性混合效应模型中参数不确定性分布的估计。
J Pharmacokinet Pharmacodyn. 2016 Dec;43(6):583-596. doi: 10.1007/s10928-016-9487-8. Epub 2016 Oct 11.
4
Comparison of robust criteria for D-optimal designs.D-最优设计的稳健准则比较
J Biopharm Stat. 2012;22(6):1193-205. doi: 10.1080/10543406.2011.580484.
5
Accurate EVSI Estimation for Nonlinear Models Using the Gaussian Approximation Method.利用高斯逼近法对非线性模型进行准确的 EVSI 估计。
Med Decis Making. 2024 Oct;44(7):787-801. doi: 10.1177/0272989X241264287. Epub 2024 Jul 31.
6
Methods of robust design of nonlinear models with an application to pharmacokinetics.非线性模型的稳健设计方法及其在药代动力学中的应用。
J Biopharm Stat. 2010 Jul;20(4):886-902. doi: 10.1080/10543401003618918.
7
dOFV distributions: a new diagnostic for the adequacy of parameter uncertainty in nonlinear mixed-effects models applied to the bootstrap.dOFV 分布:应用于自举法的非线性混合效应模型中参数不确定性充分性的一种新诊断
J Pharmacokinet Pharmacodyn. 2016 Dec;43(6):597-608. doi: 10.1007/s10928-016-9496-7. Epub 2016 Oct 11.
8
Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics.非线性混合效应模型中Fisher信息矩阵在群体药代动力学评估方面的进一步发展。
J Biopharm Stat. 2003 May;13(2):209-27. doi: 10.1081/BIP-120019267.
9
Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics.评价 Bootstrap 方法在估计非线性混合效应模型中参数不确定性的应用:群体药代动力学中的模拟研究。
J Pharmacokinet Pharmacodyn. 2014 Feb;41(1):15-33. doi: 10.1007/s10928-013-9343-z. Epub 2013 Dec 8.
10
Transform-both-sides nonlinear models for in vitro pharmacokinetic experiments.用于体外药代动力学实验的双侧变换非线性模型。
Stat Methods Med Res. 2015 Jun;24(3):306-24. doi: 10.1177/0962280214544017. Epub 2014 Jul 17.

引用本文的文献

1
Optimal sample selection applied to information rich, dense data.优化样本选择在信息丰富、密集数据中的应用。
J Pharmacokinet Pharmacodyn. 2024 Feb;51(1):33-37. doi: 10.1007/s10928-023-09883-7. Epub 2023 Aug 10.
2
Tutorial for $DESIGN in NONMEM: Clinical trial evaluation and optimization.NONMEM 设计教程:临床试验评估与优化。
CPT Pharmacometrics Syst Pharmacol. 2021 Dec;10(12):1452-1465. doi: 10.1002/psp4.12713. Epub 2021 Oct 19.

本文引用的文献

1
The effect of Fisher information matrix approximation methods in population optimal design calculations.Fisher 信息矩阵逼近方法在群体最优设计计算中的影响。
J Pharmacokinet Pharmacodyn. 2016 Dec;43(6):609-619. doi: 10.1007/s10928-016-9499-4. Epub 2016 Nov 1.
2
Influence of covariance between random effects in design for nonlinear mixed-effect models with an illustration in pediatric pharmacokinetics.非线性混合效应模型设计中随机效应协方差的影响及儿科药代动力学实例分析
J Biopharm Stat. 2014;24(3):471-92. doi: 10.1080/10543406.2014.888443.
3
Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies.
群体药代动力学-药效学研究中设计评估的方法与软件工具
Br J Clin Pharmacol. 2015 Jan;79(1):6-17. doi: 10.1111/bcp.12352.
4
Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members.药物计量学最优设计的当前应用与所需发展:一项在DDMoRe的欧洲制药工业与协会联合会成员中开展的研究
CPT Pharmacometrics Syst Pharmacol. 2013 Jun 5;2(6):e46. doi: 10.1038/psp.2013.19.
5
Comparison of robust criteria for D-optimal designs.D-最优设计的稳健准则比较
J Biopharm Stat. 2012;22(6):1193-205. doi: 10.1080/10543406.2011.580484.
6
Adaptive optimal design for bridging studies with an application to population pharmacokinetic studies.桥接研究的自适应最优设计及其在群体药代动力学研究中的应用。
Pharm Res. 2012 Jun;29(6):1530-43. doi: 10.1007/s11095-011-0659-3. Epub 2012 Feb 14.
7
Methods of robust design of nonlinear models with an application to pharmacokinetics.非线性模型的稳健设计方法及其在药代动力学中的应用。
J Biopharm Stat. 2010 Jul;20(4):886-902. doi: 10.1080/10543401003618918.
8
Robust population pharmacokinetic experiment design.稳健的群体药代动力学实验设计。
J Pharmacokinet Pharmacodyn. 2005 Feb;32(1):33-64. doi: 10.1007/s10928-005-2102-z.
9
POPED, a software for optimal experiment design in population kinetics.POPED,一款用于群体动力学中优化实验设计的软件。
Comput Methods Programs Biomed. 2004 Apr;74(1):29-46. doi: 10.1016/S0169-2607(03)00073-7.
10
STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN.香豆素类抗凝血药物的研究:华法林在人体中的药效学。
J Clin Invest. 1963 Oct;42(10):1542-51. doi: 10.1172/JCI104839.